SCOPUS 정보 검색 플랫폼

Israel Medical Association Journal

Volumn 3, Issue 9, 2001, Pages 686-690

Tumor necrosis factor inhibitors: New options for treating rheumatoid arthritis

(1) Moreland, L W a

a University of Alabama at Birmingham (United States)

Author keywords

Etanercept; Infliximab; Methotrexate; Rheumatoid arthritis; Tumor necrosis factor

Indexed keywords

ANTIBODIES; DRUG DOSAGE; PATIENT TREATMENT; TUMORS;

PATHOGENESIS;

MEDICAL APPLICATIONS;

ANTIRHEUMATIC AGENT; CYTOKINE; ETANERCEPT; HYBRID PROTEIN; INFLIXIMAB; METHOTREXATE; MONOCLONAL ANTIBODY; PLACEBO; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

BIOTECHNOLOGY; CLINICAL TRIAL; DISEASE ACTIVITY; DOSE CALCULATION; DOSE RESPONSE; DRUG ACTIVITY; DRUG APPROVAL; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG INFUSION; DRUG POTENTIATION; DRUG STRUCTURE; DRUG TARGETING; DRUG TOLERABILITY; FOOD AND DRUG ADMINISTRATION; HEADACHE; HUMAN; IMMUNOGLOBULIN CONSTANT REGION; INFLAMMATORY DISEASE; INJECTION SITE; NONHUMAN; PATHOGENESIS; REVIEW; RHEUMATOID ARTHRITIS; SKIN MANIFESTATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL AVAILABILITY; HALF-LIFE; HUMANS; IMMUNOGLOBULIN G; MICE; RANDOMIZED CONTROLLED TRIALS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035678703 PISSN: 15651088 EISSN: None Source Type: Journal
DOI: None Document Type: Review

Times cited : (6)

References (20)

1
- 0028866438
- Early rheumatoid arthritis: Time to aim for remission?
- (1995) Ann Rheum Dis , vol.54 , pp. 944-947
- Emery, P.¹ Salmon, M.²

2
- 0021714848
- The lifetime costs of rheumatoid arthritis
- (1984) J Rheumatol , vol.11 , pp. 819-827
- Stone, C.¹

3
- 0029858740
- Recombinant soluble TNF receptor (p80) fusion protein: Toxicity and dose finding trial in refractory RA
- (1996) J Rheumatol , vol.23 , pp. 1849-1855
- Moreland, L.W.¹ Margolies, G.² Heck, L.W.³ Saway, A.⁴ Blosch, C.⁵ Hanna, R.⁶ Koopman, W.J.⁷

4
- 0000241256
- A phase III trial of etanercept vs. methotrexate (MTX) in early rheumatoid arthritis
- [Abstract]
- (1999) Arthritis Rheum , vol.42 , Issue.SUPPL.
- Finck, B.¹ Martin, R.² Fleischmann, R.³ Moreland, L.⁴ Schiff, J.⁵

5
- 0013511183
- Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
- (1997) N Engl J Med , vol.337 , pp. 141-147
- Moreland, L.W.¹ Baumgartner, S.W.² Schiff, M.H.³ Tindall, E.A.⁴ Fleischmann, R.M.⁵ Weaver, A.L.⁶ Ettlinger, R.E.⁷ Cohen, S.⁸ Koopman, W.J.⁹ Mohler, K.¹⁰ Widmer, M.B.¹¹ Blosch, C.M.¹²

6
- 0033574147
- Etanercept therapy in rheumatoid arthritis. A randomized controlled trial
- (1999) Ann Intern Med , vol.130 , pp. 478-486
- Moreland, L.W.¹ Schiff, M.H.² Baumgartner, S.W.³ Tindall, E.A.⁴ Fleischmann, R.M.⁵ Bulpitt, K.J.⁶ Weaver, A.L.⁷ Keystone, E.C.⁸ Furst, D.E.⁹ Mease, P.J.¹⁰ Ruderman, E.M.¹¹ Horwitz, D.A.¹² Arkfeld, D.G.¹³ Garrison, L.¹⁴ Burge, D.J.¹⁵ Blosch, C.M.¹⁶ Lange, M.L.¹⁷ McDonnell, N.D.¹⁸ Weinblatt, M.E.¹⁹

7
- 0000141529
- Long-term use of etanercept in patients with DMARD-refractory rheumatoid arthritis
- [Abstract]
- (1999) Arthritis Rheum , vol.42 , Issue.SUPPL.
- Moreland, L.M.¹ Cohen, S.B.² Baumgartner, S.³ Schiff, M.⁴ Tindall, E.A.⁵ Burge, D.J.⁶

8
- 0033611472
- A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate
- (1999) N Engl J Med , vol.340 , pp. 253-259
- Weinblatt, M.E.¹ Kremer, J.M.² Bankhurst, A.D.³ Bulpitt, K.J.⁴ Fleischmann, R.M.⁵ Fox, R.I.⁶ Jackson, C.G.⁷ Lange, M.⁸ Burge, D.J.⁹

9
- 0000486881
- Safety and efficacy of Enbrel (etanercept) in the extended treatment of polyarticular-course JRA
- [Abstract]
- (1999) Arthritis Rheum , vol.42 , Issue.SUPPL.
- Lovell, D.J.¹ Giannini, E.H.² Lange, M.³ Burge, D.⁴ Finck, B.K.⁵

10
- 0027438710
- Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor-alpha
- (1993) Arthritis Rheum , vol.36 , pp. 1681-1690
- Elliott, M.J.¹ Maini, R.N.² Feldmann, M.³ Long-Fox, A.⁴ Charles, P.⁵ Katsikis, P.⁶ Brennan, F.M.⁷ Walker, J.⁸ Bijl, H.⁹ Ghrayeb, J.¹⁰

11
- 0028143211
- Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor-alpha (cA2) versus placebo in rheumatoid arthritis
- (1994) Lancet , vol.344 , pp. 1105-1110
- Elliott, M.J.¹ Maini, R.N.² Feldmann, M.³ Kalden, J.R.⁴ Antoni, C.⁵ Smolen, J.S.⁶ Leeb, B.⁷ Breedveld, F.C.⁸ Macfarlene, J.D.⁹ Bijl, H.¹⁰

12
- 0028143212
- Repeated therapy with monoclonal antibody to tumour necrosis factor-alpha (cA2) in patients with rheumatoid arthritis
- (1994) Lancet , vol.344 , pp. 1125-1127
- Elliott, M.J.¹ Maini, R.N.² Feldmann, M.³ Long-Fox, A.⁴ Charles, P.⁵ Bijl, H.⁶ Woody, J.N.⁷

13
- 0031660364
- Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
- (1998) Arthritis Rheum , vol.41 , pp. 1552-1563
- Maini, R.N.¹ Breedveld, F.C.² Kalden, J.R.³ Smolen, J.S.⁴ Davis, D.⁵ Macfarlane, J.D.⁶ Antoni, C.⁷ Leeb, B.⁸ Elliott, M.J.⁹ Woody, J.N.¹⁰ Schaible, T.F.¹¹ Feldmann, M.¹²

14
- 0033524159
- Infliximab (chimeric anti-tumor necrosis factor a monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomized phase III trial
- (1999) Lancet , vol.354 , pp. 1932-1939
- Maini, R.¹ St. Clair, E.W.² Breedveld, F.³ Furst, D.⁴ Kalden, J.⁵ Weisman, M.⁶ Smolen, J.⁷ Emery, P.⁸ Harriman, G.⁹ Feldmann, M.¹⁰ Lipsky, P.¹¹

15
- 0027201923
- Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy
- (1993) Arthritis Rheum , vol.36 , pp. 1070-1079
- Barrera, P.¹ Boerbooms, A.M.² Janssen, E.M.³ Sauerwein, R.W.⁴ Gallati, H.⁵ Mulder, J.⁶ De Boo, T.⁷ Demacker, P.N.⁸ Van De Putte, L.B.⁹ Van Der Meer, J.W.¹⁰

16
- 0026039673
- Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis
- (1991) EMBO J , vol.10 , pp. 4025-4031
- Keffer, J.¹ Probert, L.² Cazlaris, H.³ Georgopoulos, S.⁴ Kaslaris, E.⁵ Kioussis, D.⁶ Kollias, G.⁷

17
- 0026644298
- Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis
- (1992) Proc Natl Acad Sci USA , vol.89 , pp. 9784-9788
- Williams, R.O.¹ Feldman, M.² Maini, R.N.³

18
- 0023712236
- Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum
- (1988) Arthritis Rheum , vol.31 , pp. 1041-1045
- Saxne, T.¹ Palladino, M.A.² Heinegard, D.³ Talal, N.⁴ Wollheim, F.A.⁵

19
- 0029044362
- American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis
- (1995) Arthritis Rheum , vol.38 , pp. 727-735
- Felson, D.T.¹ Anderson, J.J.² Boers, M.³ Bombardier, C.⁴ Furst, D.⁵ Goldsmith, C.⁶ Katz, L.M.⁷ Lightfoot, R.⁸ Paulus, H.⁹ Strand, V.¹⁰

20
- 0025266158
- Analysis of improvement in individual rheumatoid arthritis patients treated with disease modifying anti-rheumatic drugs, based on the findings in patients treated with placebo
- (1990) Arthritis Rheum , vol.33 , pp. 477-484
- Paulus, H.E.¹ Egger, M.J.² Ward, J.R.³ Williams, H.J.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.